Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia
Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: Validity of the hemophilia joint health score
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study
Guidelines for the management of hemophilia
Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives
Gene therapy for hemophilia
Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia
Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)
Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A
